Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Dec 2017 for PharMerica CORP, €1.4M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Robert A. Oakley: trading record in brief
Robert A. Oakley discloses dealings in PharMerica Corp to SEC (Form 4). In total, 3 filings cover trades dated from 17 June 2016 to 7 December 2017.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 8 December 2017, reports a transaction of €1.4M in PharMerica Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert A. Oakley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
57,275 shares@ US$29.25100.0% of flowCommon Stock, $0.01 par valueSEC:0001209191-17-064775:0
4,817 shares0Common Stock, $0.01 par valueSEC:0001209191-17-040550:0
5,167 shares0Common Stock, $0.01 par valueSEC:0001209191-16-129057:0
3 of 3 declarations
